Novavax | Fremdkapital





Fremdkapital Veränderung Datum
Adma Biologics USD 70.08M 3.32M 2025-09
Agenus USD 23.6M 448K 2025-09
AstraZeneca USD 26.14B 19.58B 2025-12
BioCryst Pharmaceuticals USD 194.37M 48.43M 2025-09
Cassava Sciences USD 0 0 2024-12
Dynavax Technologies USD 220.97M 214K 2025-09
Geron USD 119.26M 273K 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
MannKind USD 303.65M 72.94M 2025-09
Merck USD 39.97B 6B 2025-09
Minerva Neurosciences USD 0 86.58M 2024-09
Moderna USD 26M 6M 2025-09
Novartis USD 24.24B 174M 2025-09
Novavax USD 223.63M 187K 2024-09
Pfizer USD 57.41B 93M 2025-09
Sanofi EUR 15.72B 2.45B 2025-12
Sarepta Therapeutics USD 1.04B 104.31M 2025-09
TG Therapeutics USD 245.34M 303K 2025-09


Novavax Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.